Asthma Treatment; The treatment guide line accourning the NICE Guide line,

Just 35% of people with asthma are receiving the most basic level of asthma care, according to the fifth annual asthma survey from charity Asthma UK.

The survey, which received 7,611 responses, highlighted that the number of patients receiving an asthma action plan had increased by 19.9% since 2013 but the number of inhaler technique reviews and annual asthma reviews had both reduced by 3% and 1.7% respectively, since 2015.

The survey also found that there was significant variation across the UK for people with asthma — 48.2% of people with asthma in Northern Ireland reported receiving basic asthma care compared with 27.6% in London. Inequalities also existed in relation to age, as just a quarter of people aged 18–29 received basic asthma care, compared with 41.7% of people aged 70–79.

Furthermore, it found that two-thirds of people with asthma who attended hospital did not receive a follow-up appointment within two working days, despite NICE guidance.

Anna Murphy, consultant respiratory pharmacist at University Hospitals of Leicester NHS Trust, said she was not surprised, but disappointed, that the levels of asthma care had not improved more over the years.

“It is a challenge in primary care to encourage patients to attend their annual review, often because the value of the review is not understood by the patient,” she said.

“Asthma is a chronic disease with variable symptoms — why attend if you perceive yourself to be well?”

Murphy added that inhaler technique is fundamental for asthma care and that was it disappointing that the percentage of patients who have had their technique checked has not increased over the last few years.

“It is the responsibility of the prescriber to ensure that the drug can be administered, but all healthcare professionals that the patients comes into contact with should ensure that the patient can use their inhaler and optimise drug administration to the lung,” she said.

The survey also found that more than half of respondents said they used some form of technology to manage their healthcare, although only 8.3% said that they used an asthma-specific app.

References

1.  British Guideline 2009, p. 4
2. “Asthma Fact sheet №307”. WHO. November 2013. Archived from the original on June 29, 2011. Retrieved 3 March 2016.
3. Martinez F. D. (2007). “Genes, environments, development and asthma: a reappraisal”. European Respiratory Journal. 29 (1): 179–84. doi:10.1183/09031936.00087906. PMID 17197483.
4. Lemanske, R. F.; Busse, W. W. (February 2010). “Asthma: clinical expression and molecular mechanisms”. J. Allergy? Clin. Immunol. 125 (2 Suppl 2): S95–102. doi:10.1016/j.jaci.2009.10.047. PMC 2853245 . PMID 20176271.
5. NHLBI Guideline 2007, pp. 169–172
6. NHLBI Guideline 2007, p. 214
7. GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577 . PMID 27733282.
8. GBD 2015 Mortality and Causes of Death, Collaborators. (8 October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015”. Lancet. 388(10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903 . PMID 27733281.
9.  NHLBI Guideline 2007, pp. 11–12
10. Yawn B. P. (September 2008). “Factors accounting for asthma variability: achieving optimal symptom control for individual patients” (PDF). Primary Care Respiratory Journal. 17 (3): 138–147. doi:10.3132/pcrj.2008.00004. PMID 18264646. Archived (PDF) from the original on 2010-03-04.